Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · IEX Real-Time Price · USD
+0.021 (3.97%)
Apr 23, 2024, 2:41 PM EDT - Market open

Eyenovia Statistics

Total Valuation

Eyenovia has a market cap or net worth of $26.82 million. The enterprise value is $27.46 million.

Market Cap 26.82M
Enterprise Value 27.46M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

Eyenovia has 50.61 million shares outstanding. The number of shares has increased by 21.94% in one year.

Shares Outstanding 50.61M
Shares Change (YoY) +21.94%
Shares Change (QoQ) +20.69%
Owned by Insiders (%) 16.20%
Owned by Institutions (%) 22.44%
Float 36.54M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6,925.31
Forward PS 5.42
PB Ratio 2.91
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7,250.51
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.17, with a Debt / Equity ratio of 1.79.

Current Ratio 2.17
Quick Ratio 1.57
Debt / Equity 1.79
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -10.49

Financial Efficiency

Return on equity (ROE) is -213.30% and return on invested capital (ROIC) is -101.27%.

Return on Equity (ROE) -213.30%
Return on Assets (ROA) -89.20%
Return on Capital (ROIC) -101.27%
Revenue Per Employee $66
Profits Per Employee -$478,265
Employee Count 57
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -89.35% in the last 52 weeks. The beta is 1.66, so Eyenovia's price volatility has been higher than the market average.

Beta (1Y) 1.66
52-Week Price Change -89.35%
50-Day Moving Average 1.34
200-Day Moving Average 1.63
Relative Strength Index (RSI) 24.44
Average Volume (30 Days) 1,209,072

Short Selling Information

The latest short interest is 5.22 million, so 10.31% of the outstanding shares have been sold short.

Short Interest 5.22M
Short Previous Month 3.57M
Short % of Shares Out 10.31%
Short % of Float 14.29%
Short Ratio (days to cover) 3.19

Income Statement

In the last 12 months, Eyenovia had revenue of $3,787 and -$27.26 million in losses. Loss per share was -$0.66.

Revenue 3,787
Gross Profit 7,574
Operating Income -25.40M
Pretax Income -27.26M
Net Income -27.26M
EBITDA -24.11M
EBIT -24.89M
Loss Per Share -$0.66
Full Income Statement

Balance Sheet

The company has $14.85 million in cash and $16.08 million in debt, giving a net cash position of -$1.23 million or -$0.02 per share.

Cash & Cash Equivalents 14.85M
Total Debt 16.08M
Net Cash -1.23M
Net Cash Per Share -$0.02
Equity / Book Value 9.00M
Book Value Per Share 0.18
Working Capital 11.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.84 million and capital expenditures -$3.97 million, giving a free cash flow of -$27.81 million.

Operating Cash Flow -23.84M
Capital Expenditures -3.97M
Free Cash Flow -27.81M
FCF Per Share -$0.68
Full Cash Flow Statement


Gross margin is 200.00%, with operating and profit margins of -670,685.82% and -719,859.94%.

Gross Margin 200.00%
Operating Margin -670,685.82%
Pretax Margin -719,859.94%
Profit Margin -719,859.94%
EBITDA Margin -636,547.06%
EBIT Margin -657,228.55%
FCF Margin -734,277.16%

Dividends & Yields

Eyenovia does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.94%
Shareholder Yield -21.94%
Earnings Yield -103.95%
FCF Yield -106.03%

Analyst Forecast

The average price target for Eyenovia is $10.00, which is 1,762.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 1,762.20%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 720.21%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Eyenovia has an Altman Z-Score of -8.67 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -8.67
Piotroski F-Score 1